Status:
COMPLETED
Vitamin D Supplementation on Outcome and Disease Activity.
Lead Sponsor:
Department of Medical Services Ministry of Public Health of Thailand
Conditions:
Rheumatoid Arthritis, Vitamin D , Disease Activity, DAS28ESR
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To study efficacy of Vitamin D on outcome and disease activity ; DAS28-ESR in Rheumatoid arthritis patients at Rajavithi hospital .
Eligibility Criteria
Inclusion
- Age \> 18 yrs old
- RA diagnosed by ACR/EULAR 2010
- low to moderate disease activity
- on stable NSAIDs and DMARDs for at least 1 month
- Received Prednisolone less than or equal to 7.5 mg/day
- serum calcium, phosphorus and ALP are within normal limit.
Exclusion
- Chronic kidney disease stage 3 or higher
- History of TB
- History of Chronic liver disease
- Pregnancy or breast-feeding
- adjustment of immuno-suppressive drugs, steroid
- other connective tissue disease
- Vitamin D allergy
- received other drugs which have vitamin D component
- serum Vitamin D less than 10 ng/mL
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04909931
Start Date
May 1 2021
End Date
December 1 2022
Last Update
January 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rajavithi hospital
Bangkok, Bangkok, Thailand